Cargando…
Bioengineered Nisin Derivative M17Q Has Enhanced Activity against Staphylococcus epidermidis
Staphylococcus epidermidis is frequently implicated in medical device-related infections. As a result of this, novel approaches for control of this opportunistic pathogen are required. We examined the ability of the natural peptide nisin A, produced by Lactococcus lactis, to inhibit S. epidermidis....
Autores principales: | Twomey, Ellen, Hill, Colin, Field, Des, Begley, Maire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345907/ https://www.ncbi.nlm.nih.gov/pubmed/32517174 http://dx.doi.org/10.3390/antibiotics9060305 |
Ejemplares similares
-
A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
por: Field, Des, et al.
Publicado: (2015) -
Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
por: Field, Des, et al.
Publicado: (2012) -
A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms
por: Pérez-Ibarreche, Mariana, et al.
Publicado: (2021) -
Studies with bioengineered Nisin peptides highlight the broad‐spectrum potency of Nisin V
por: Field, Des, et al.
Publicado: (2010) -
Bioengineered Nisin A Derivatives Display Enhanced Activity against Clinical Neonatal Pathogens
por: Desmond, Anna, et al.
Publicado: (2022)